{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:17:29Z","timestamp":1789654649948,"version":"4.0.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:p>Nonpsychoactive phytocannabinoids (pCBs) from <jats:italic toggle=\"yes\">Cannabis sativa<\/jats:italic> may represent novel therapeutic options for cachexia because of their pleiotropic pharmacological activities, including appetite stimulation. We have recently shown that purified cannabigerol (CBG) is a novel appetite stimulant in rats. As standardized extracts from <jats:italic toggle=\"yes\">Cannabis<\/jats:italic> chemotypes dominant in one pCB [botanical drug substances (BDSs)] often show greater efficacy and\/or potency than purified pCBs, we investigated the effects of a CBG-rich BDS, devoid of psychoactive \u2206<jats:sup>9<\/jats:sup>-tetrahydrocannabinol, on feeding behaviour. Following a 2\u2009h prefeed satiation procedure, 16 male Lister-hooded rats were administered CBG-BDS (at 30\u2013240\u2009mg\/kg) or vehicle. Food intake, meal pattern microstructure and locomotor activity were recorded over 2\u2009h. The total food intake was increased by 120 and 240\u2009mg\/kg CBG-BDS (1.53 and 1.36\u2009g, respectively, vs. 0.56\u2009g in vehicle-treated animals). Latency to feeding onset was dose dependently decreased at all doses, and 120 and 240\u2009mg\/kg doses increased both the number of meals consumed and the cumulative size of the first two meals. No significant effect was observed on ambulatory activity or rearing behaviour. CBG-BDS is a novel appetite stimulant, which may have greater potency than purified CBG, despite the absence of \u2206<jats:sup>9<\/jats:sup>-tetrahydrocannabinol in the extract.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000285","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:43:35Z","timestamp":1485384215000},"page":"280-284","source":"Crossref","is-referenced-by-count":31,"title":["A cannabigerol-rich Cannabis sativa extract, devoid of \u22069-tetrahydrocannabinol, elicits hyperphagia in rats"],"prefix":"10.1097","volume":"28","author":[{"given":"Daniel I.","family":"Brierley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Samuels","sequence":"additional","affiliation":[{"name":"School of Psychology and Clinical Language Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnie","family":"Duncan","sequence":"additional","affiliation":[{"name":"GW Research Ltd, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Whalley","sequence":"additional","affiliation":[{"name":"School of Chemistry, Food and Nutritional Sciences, and Pharmacy, University of Reading, Reading"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Williams","sequence":"additional","affiliation":[{"name":"School of Psychology and Clinical Language Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","article-title":"Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid","volume":"35","author":"Borrelli","year":"2014","journal-title":"Carcinogenesis"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00213-016-4397-4","article-title":"Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats","volume":"233","author":"Brierley","year":"2016a","journal-title":"Psychopharmacology (Berl)"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-015-4100-1","article-title":"Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea","volume":"233","author":"Brierley","year":"2016b","journal-title":"Psychopharmacology (Berl)"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.tips.2015.08.010","article-title":"Polypharmacology shakes hands with complex aetiopathology","volume":"36","author":"Brodie","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","article-title":"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), \u03949-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10681-005-1164-8","article-title":"The inheritance of chemical phenotype in Cannabis sativa L. (II): cannabigerol predominant plants","volume":"145","author":"De Meijer","year":"2005","journal-title":"Euphytica"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ptr.3375","article-title":"Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation","volume":"25","author":"Farrimond","year":"2011","journal-title":"Phytother Res"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-012-2697-x","article-title":"Cannabinol and cannabidiol exert opposing effects on rat feeding patterns","volume":"223","author":"Farrimond","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bph.12321","article-title":"Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism","volume":"170","author":"Hill","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/en.2013-1823","article-title":"Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats","volume":"155","author":"Mattace Raso","year":"2014","journal-title":"Endocrinology"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","article-title":"Synergy research: approaching a new generation of phytopharmaceuticals","volume":"16","author":"Wagner","year":"2009","journal-title":"Phytomedicine"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201706000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:12:08Z","timestamp":1694333528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201706000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000285","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}